Introduction: The aim of the current study was to investigate the relationship between lung involvement of SARS-CoV-2 and antibody levels of COVID-19 patients 3 and 6 months from the disease. Metho...
Aim: COVID-19, caused by SARS-CoV-2, started in December 2019 and has spread across the world. Materials & methods: We analyzed real-time PCR results of 10,000 samples from 2 April to 30 May 2020 i...
Aim: Our aim was to investigate the differences between healthy people and COVID-19 patients in terms of some immunological biomolecules, especially including those related to the inflammation proc...
Background: Fibromyalgia syndrome (FMS) is a syndrome that commonly affects the musculoskeletal system and is characterized by fatigue and body aches. Recent studies have demonstrated a relationship between FMS and certain immunological markers. In this study, we investigated the relationship between MMP-3, IL-6, IL-6R, and TNF-α serum levels and disease impact (FIQ score) in FMS patients. Methods: This case–control study consisted of 164 participants, of whom 82 were patients with fibromyalgia syndrome (FMS) and 82 were healthy controls without FMS, chronic pain, or inflammatory diseases. Disease impact was assessed using the Fibromyalgia Impact Questionnaire (FIQ). MMP-3, IL-6, IL-6R, and TNF-α serum levels were detected using enzyme-linked immunosorbent assay (ELISA) kits. Results: In patients diagnosed with FMS, TNF-α, IL-6, IL-6R, and MMP-3 levels were significantly higher than those of the control group (all p < 0.0001). MMP-3, IL-6, IL-6R, and TNF-α levels correlated positively with the FIQ score. Conclusions: This study highlights the involvement of inflammatory processes in FMS, particularly the role of serum IL-6, TNF-α, IL-6R, and MMP-3 levels in the pathophysiology of FMS. The results indicate that inflammatory markers may be associated with the severity of FMS and may have potential as disease markers.
7 March 2022 in Journal of Pediatric Infectious Diseases
Objective We aimed to investigate the relationship between serum endocan, procalcitonin (PCT), C-reactive protein (CRP), white blood cell count (WBC), neutrophil/lymphocyte ratios (NLR), and the severity of the disease in childhood community-acquired pneumonia (CAP) cases. Methods This cross-sectional designed study included 30 pneumonia cases and 30 severe pneumonia cases aged between 3 months and 18 years who were hospitalized and treated in our hospital with the diagnosis of CAP. We also included 30 healthy controls in the same age range. Pearson's correlation and receiver operating characteristic (ROC) curve analyzes were performed. Results PCT, endocan, NLR, and CRP levels were found to be significantly higher in patients with severe pneumonia. Sensitivity and specificity values in detecting pneumonia were 72.5 and 93% for PCT, 78.4 and 83.3% for CRP, 78.4 and 76.7% for endocan, and 64.7 and 63.3% for NLR. However, the area under the curve in ROC analysis were 0.821, 0.840, 0.842, and 0.670 for PCT, CRP, endocan, and NLR respectively. Conclusion Endocan may be a marker of the diagnosis of pneumonia and not clinical severity, but studies are needed in large patient populations.
1. SARS-CoV-2 first emerged in Wuhan, China, in late 2019, with global spread following in early 2020, rapidly evolving into a pandemic that placed considerable strain on healthcare systems worldwi...